A detailed history of Silicon Valley Capital Partners transactions in Organon & Co. stock. As of the latest transaction made, Silicon Valley Capital Partners holds 45 shares of OGN stock, worth $661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 44 2.27%
Holding current value
$661
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$18.65 - $23.03 $18 - $23
1 Added 2.27%
45 $0
Q2 2024

Oct 29, 2024

BUY
$17.45 - $21.96 $17 - $21
1 Added 2.33%
44 $0
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $10 - $17
1 Added 2.38%
43 $0
Q3 2023

Nov 03, 2023

BUY
$16.59 - $23.77 $16 - $23
1 Added 2.44%
42 $0
Q1 2023

May 09, 2023

BUY
$21.42 - $32.08 $21 - $32
1 Added 2.5%
41 $0
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $932 - $1,144
40 New
40 $1,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.74B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.